MedPath

LEE'S PHARMACEUTICAL (HK) LIMITED

🇭🇰Hong Kong, China
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

34

PPB:34

Drug Approvals

NATULAN CAPSULES 50MG

Approval Date
Nov 29, 2021
PPB

TEGLUTIK ORAL SUSPENSION 5MG/ML

Approval Date
Oct 27, 2021
PPB

ADASUVE INHALATION POWDER, PRE-DISPENSED 9.1MG

Approval Date
Oct 5, 2021
PPB

CETRAXAL PLUS EAR DROPS, SOLUTION IN SINGLE-DOSE CONTAINER 3MG/ML + 0.25MG/ML

Approval Date
Dec 14, 2020
PPB

INTRAROSA PESSARIES 6.5MG

Approval Date
Apr 24, 2020
PPB

OMACOR CAPSULES 1000MG

Approval Date
Nov 6, 2019
PPB

LUTRATE 3 MONTH DEPOT POWDER AND SOLVENT FOR PROLONGED-RELEASE SUSPENSION FOR INJECTION 22.5MG

Approval Date
Aug 28, 2018
PPB

LUTRATE DEPOT POWDER AND SOLVENT FOR PROLONGED-RELEASE SUSPENSION FOR INJECTION 3.75MG

Approval Date
Mar 20, 2015
PPB

ZANIDIP TAB 20MG

Approval Date
Aug 9, 2012
PPB

DROPAXIN ORAL DROPS 10MG/ML

Approval Date
Sep 1, 2011
PPB
  • Prev
  • 1
  • 2
  • 3
  • 4
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.